Angewandte Chemie International Edition · 2021 · 13 citations · 31 references
EngineeringBiochemistryPharmacologyBiocatalysisDrug MetabolismEnzymologyBiocatalyst EngineeringBiocatalyst ScreeningComputational Enzyme DesignDrug-metabolizing EnzymesEnzyme DiscoveryEnzyme-substrate RecognitionCatalytic EfficiencyCatalytic Efficiency OptimizationCatalytic SpecificityCocaine ToxicityCrystal Structure PredictionElimination MechanismsEnzyme-mediated Drug MetabolismStructure-based Enzyme Design
Abstract Benzoylecgonine (BZE) is the major toxic metabolite of cocaine and is responsible for the long‐term cocaine‐induced toxicity owing to its long residence time in humans. BZE is also the main contaminant following cocaine consumption. Here, we identified the bacterial cocaine esterase (CocE) as a BZE‐metabolizing enzyme (BZEase), which can degrade BZE into biological inactive metabolites (ecgonine and benzoic acid). CocE was redesigned by a reactant‐state‐based enzyme design theory. An encouraging mutant denoted as BZEase2, presented a >400‐fold improved catalytic efficiency against BZE compared with wild‐type (WT) CocE. In vivo, a single dose of BZEase2 (1 mg kg −1 , IV) could eliminate nearly all BZE within only two minutes, suggesting the enzyme has the potential for cocaine overdose treatment and BZE elimination in the environment by accelerating BZE clearance. The crystal structure of a designed BZEase was also determined.
31
The penultimate rotamer library
Simon C. Lovell, J. Michael Word, Jane S. Richardson et al. · Proteins Structure Function and Bioinformatics · 2000 · 1K citations
De Novo Enzyme Design Using Rosetta3
Florian Richter, Andrew Leaver‐Fay, Sagar D. Khare et al. · PLoS ONE · 2011 · 362 citations · Full text